When used as adjunctive therapy with outpatient buprenorphine, a prescription digital therapeutic was cost-effective at a $50,000 willingness-to-pay threshold, researchers concluded.
When used as adjunctive therapy with outpatient buprenorphine, a prescription digital therapeutic was cost-effective at a $50,000 willingness-to-pay threshold, researchers concluded.
When used as adjunctive therapy...